Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- DY -18.9%, CHS -10.6%, FRO -8%, HRB -5.6%, SCSC -3.7%, OLLI -3.3%, SBGL-2.5%
Other news:
- OTIC -80.8% (announces results for its AVERTS-1 Phase 3 clinical trial of OTIVIDEX in patients with Ménière's disease; missed primary endpoint and all key vertigo secondary endpoint)
- XTNT -4.2% (CFO John Gandolfo tenders resignation)
- DRYS -4.1% ( to launch its previously announced rights offering of shares of common stock)
- ASML -1.1% (may be related to investor conference presentation)
Analyst comments:
- COTY -0.9% (downgraded to Sell from Hold at Berenberg)
- VNO -0.5% (downgraded to Hold from Buy at Stifel)